Shan-Shan Wang's Roam Technologies Wins Sydney Startup World Cup Spot For Silicon Valley

Sydney founder Shan-Shan Wang will take Roam Technologies to Silicon Valley after winning the Sydney regional final of the Startup World Cup, giving Greater Sydney a founder-led business story with a clear international next step.

Startup Daily reported on 26 June that Wang, who is developing a handheld oxygen device through Roam Technologies, won the Sydney leg of the competition and will represent Australia at the global finals in San Francisco in November. The result puts a Sydney medtech founder into a global pitch pathway run through Pegasus Tech Ventures, with regional events feeding into a final at the Hilton Union Square.

The practical local angle is not just that a Sydney founder won a pitch night. It is that the competition has become another test of how the city converts university, hospital, engineering and startup talent into exportable companies. Roam Technologies' device, Juno, is described in the source coverage as a world-first handheld oxygen device designed for everyday use in chronic conditions, with early traction in the United States. That gives the story a direct health, manufacturing and commercialisation edge.

The Sydney regional field was described as the most competitive in the Australian series, with 180 applications and 11 founders on stage. The program gave written feedback to applicants and pitch training to the top founders before the live final. That structure matters for local founders because it makes the event more than a single winner-takes-all evening. Even founders who do not travel to San Francisco can leave with investor feedback, sharper pitch materials and contacts that may help with the next raise or customer conversation.

Wang joins Melbourne winner Tori Fox from Arelis in the national pathway. The Sydney event also named Berlin Raj of Totex Energy as the People's Vote winner, a sign that climate technology is still pulling attention from the local startup community. The cohort listed by Startup Daily stretched across medtech, climate, robotics, campus life, supply chain and other software-led fields, showing that the Sydney pipeline is not confined to one fashionable category.

The judges included investors and ecosystem figures from organisations such as Epic Execution, Founder Institute, Bailador Technology Investments, Galileo Ventures, Arcanys Ventures, Birchal and Black Nova Venture Capital. For Sydney readers, that mix is useful because it shows the route from a founder event to later capital and operating support.

The win also lands at a time when Sydney is trying to define its post-SXSW startup calendar. Founder events are easy to announce and harder to make useful. This one produced a concrete outcome: a Sydney medtech founder has a named company, a named product, a confirmed international final, and a date in November when the local result will be tested against global competition.

For the Sydney and Surrounds audience, the most useful way to read the result is through the local operator lens. A founder building a medical device has to move through product development, regulatory expectations, customer discovery, manufacturing decisions and capital raising before a public win turns into a durable company. The Startup World Cup pathway does not solve those steps, but it gives Wang a larger room in which to test the story. It also gives other Sydney founders a visible example of a practical route from a local stage to an international investor audience without pretending that the pitch alone is the business.